肥胖是否与髋膝关节置换术后深静脉血栓或肺栓塞风险增加相关?一项大型数据库研究
该研究基于2008至2016年美国外科医师学会国家手术质量改进计划数据库,评估初次及翻修全髋与全膝关节置换术后30天深静脉血栓、肺栓塞及静脉血栓栓塞症发生率与体重指数(BMI)的关系。结果显示,按世界卫生组织分类的超重或肥胖与肺栓塞风险升高相关,但与深静脉血栓风险无关;作者认为现有数据不支持对无其他静脉血栓栓塞症危险因素的肥胖患者增加抗凝。
要点
- 初次及翻修全髋与全膝关节置换术后,超重或肥胖与肺栓塞风险升高相关,但与深静脉血栓风险无关。
- 初次全髋关节置换术后,II级肥胖者肺栓塞风险比值比为2.36(95%CI 1.23-4.50,p=0.009)。
- 初次全膝关节置换术后,超重者肺栓塞风险比值比为1.56(95%CI 1.03-2.36,p=0.035)。
核心结论
- 该大型行政数据库研究提示,初次全髋或全膝关节置换术后,患者分类为超重或肥胖与肺栓塞风险增加相关,但与深静脉血栓风险无关。
- 由于积极药物抗凝可降低深静脉血栓率但未显示影响肺栓塞率或死亡率,现有数据不支持对无其他静脉血栓栓塞症危险因素的肥胖患者增加抗凝。
- 需要额外研究来优化静脉血栓栓塞症预防方案,以降低肺栓塞风险同时维持可接受的术后出血风险。
研究设计与样本
- 研究回顾了2008至2016年美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库。
- 研究评估了初次全髋关节置换、初次全膝关节置换、翻修全髋关节置换和翻修全膝关节置换术后30天深静脉血栓、肺栓塞及合并静脉血栓栓塞症的报告发生率。
- 体重指数按连续变量及按世界卫生组织切点分类的类别变量(体重不足、正常体重、超重、肥胖)进行分析。
- 该数据库经风险调整并设计用于捕获术后并发症,诊断纳入需治疗的任何深静脉血栓或肺栓塞,未区分近端与远端深静脉血栓。
- 采用多变量逻辑回归控制年龄、性别、种族、美国麻醉医师学会评分、糖尿病、高血压、吸烟状态、全身麻醉和低白蛋白血症,以确定肥胖是否独立关联深静脉血栓和肺栓塞风险。
主要发现
- 控制医疗合并症和手术类型等潜在混杂变量后,按世界卫生组织分类为体重不足(BMI<18.5 kg/m²)、超重(BMI 25-29.9 kg/m²)、I级肥胖(BMI 30-34.9 kg/m²)、II级肥胖(BMI 35-39.9 kg/m²)或III级肥胖(BMI≥40 kg/m²)的初次及翻修全髋与全膝关节置换患者,与正常体重(BMI 18.5-25 kg/m²)患者相比,未显示深静脉血栓风险增加的相关性。
- 与正常体重的初次全髋关节置换患者相比,II级肥胖患者肺栓塞风险升高(比值比2.36;95%CI 1.23-4.50;p=0.009),所有更重类别也升高。
- 与正常体重的全膝关节置换患者相比,超重患者肺栓塞风险升高(比值比1.56;95%CI 1.03-2.36;p=0.035),所有更重类别也升高。
关键数值与推荐
- 体重指数分类采用世界卫生组织切点:体重不足<18.5 kg/m²,正常体重18.5-25 kg/m²,超重25-29.9 kg/m²,I级肥胖30-34.9 kg/m²,II级肥胖35-39.9 kg/m²,III级肥胖≥40 kg/m²。
临床怎么用
- 作者认为,现有数据不支持对无其他静脉血栓栓塞症危险因素的肥胖患者在接受全髋或全膝关节置换时增加抗凝。
- 作者建议需要额外研究来优化静脉血栓栓塞症预防方案,以降低肺栓塞风险同时维持可接受的术后出血风险。
局限性
- 该数据库未区分近端与远端深静脉血栓。
- 作者指出需要额外研究来优化静脉血栓栓塞症预防方案,以降低肺栓塞风险同时维持可接受的术后出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep venous thrombosis (DVT) and pulmonary embolus (PE) remain an important cause of morbidity and mortality after THA and TKA. Prior recommendations have advocated for more aggressive prophylaxis for patients with obesity, whereas the evidence supporting these recommendations is conflicting and often based on underpowered studies. QUESTIONS/PURPOSES: (1) What is the association between obesity and DVT and PE after primary and revision THA and TKA? (2) Is there a body mass index (BMI) threshold beyond which DVT and PE risk is elevated? METHODS: We reviewed the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2008 to 2016 to evaluate the reported 30-day rates of DVT, PE, and combined venous thromboembolism (VTE) after primary THA, primary TKA, revision THA, and revision TKA according to BMI as a continuous variable and a categorical variable as defined by the World Health Organization cutoffs for underweight, normal weight, overweight, and obesity. This database is risk-adjusted and designed to capture complications after surgery, thus making it ideal for this study. The diagnosis of DVT and PE is included in the ACS-NSQIP database for any DVT or PE requiring treatment. Proximal versus distal DVT is not specified within the database. Multivariate logistic regression was performed to determine if obesity was independently associated with DVT and PE risk by controlling for age, sex, race, American Society of Anesthesiologists score, diabetes, hypertension, smoking status, general anesthesia, and hypoalbuminemia. RESULTS: After controlling for potential confounding variables such as medical comorbidities and procedure type, patients undergoing primary and revision THA and TKA with World Health Organization classification as underweight (BMI < 18.5 kg/m), overweight (BMI 25-29.9 kg/m), Class I obese (BMI 30-34.9 kg/m), Class II obese (BMI 35-39.9 kg/m), or Class III obese (BMI ≥ 40 kg/m) did not demonstrate an association with increased risk of DVT compared with patients classified as normal weight (BMI 18.5-25 kg/m). Compared with patients undergoing primary THA classified as normal weight, the risk of PE was elevated in patients with Class II obesity (odds ratio [OR], 2.36; 95% confidence interval [CI], 1.23-4.50; p = 0.009) and all heavier categories. Compared with patients undergoing TKA classified as normal weight, the risk of PE was elevated in patients classified as overweight (OR, 1.56; 95% CI, 1.03-2.36; p = 0.035) and all heavier categories. CONCLUSIONS: This large administrative database study suggests that patient classification as overweight or obese is associated with increased risk of development of PE but not DVT after primary THA or TKA. Because aggressive pharmacologic anticoagulation regimens can decrease the DVT rate but have not been shown to affect the rate of PE or death, the data do not currently support increased anticoagulation in patients with obesity without other risk factors for VTE undergoing THA or TKA. Additional studies are required to refine VTE prophylaxis protocols to reduce PE risk while maintaining acceptable postoperative bleeding risk. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Sloan M, Sheth N, Lee GC, et al. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study. Clin Orthop Relat Res. 2019. PMID: 30624321. doi:10.1097/CORR.0000000000000615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。